U.S. allows Merck’s COVID-19 pill amid safety, variant concerns | Science
The U.S Food and Drug Administration (FDA) on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. While Pfizer’s antiviral may prove to be more effective, and Merck’s pill has left some scientists questioning the dangers behind its mechanism of action, molnupiravir will be another weapon in the armamentarium of … Read more